Insider · CIK 0001874108
John Nuss
officer
Files at VTYX (Ventyx Biosciences, Inc.). First filing Dec 19, 2024, latest Dec 19, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $179k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 18Weak | Ventyx Biosciences, Inc. | $98k 12,675 shares | -3% | - | |
| 15Weak | VTYXsell Ventyx Biosciences, Inc. | $2,019 1,887 shares | -0% | - | |
| 22Weak | VTYXsell Ventyx Biosciences, Inc. | $50k 21,119 shares | -4% | - | |
| 5Weak | VTYXsell Ventyx Biosciences, Inc. | $30k 13,161 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | VTYX Ventyx Biosciences, Inc. | MOption exercise Common Stock | +34,930 | $0.00 | $0 | 502,156 | Dec 19, 2025 |
| Dec 18, 2025 | VTYX Ventyx Biosciences, Inc. | SOpen-market sale Common Stock | -12,675 | $7.72 | $98k | 489,481 | Dec 19, 2025 |
| Dec 17, 2025 | VTYX Ventyx Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -34,930 | $0.00 | $0 | 0 | Dec 19, 2025 |
| Apr 2, 2025 | VTYX Ventyx Biosciences, Inc. | SOpen-market sale Common Stock | -1,887 | $1.07 | $2,019 | 467,226 | Apr 3, 2025 |
| Mar 28, 2025 | VTYX Ventyx Biosciences, Inc. | MOption exercise Common Stock | +4,531 | $0.00 | $0 | 469,113 | Apr 1, 2025 |
| Mar 28, 2025 | VTYX Ventyx Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -4,531 | $0.00 | $0 | 9,063 | Apr 1, 2025 |
| Dec 27, 2024 | VTYX Ventyx Biosciences, Inc. | SOpen-market sale Common Stock | -21,119 | $2.36 | $50k | 464,582 | Dec 30, 2024 |
| Dec 17, 2024 | VTYX Ventyx Biosciences, Inc. | MOption exercise Common Stock | +34,930 | $0.00 | $0 | 498,862 | Dec 19, 2024 |
| Dec 19, 2024 | VTYX Ventyx Biosciences, Inc. | SOpen-market sale Common Stock | -13,161 | $2.26 | $30k | 485,701 | Dec 19, 2024 |
| Dec 17, 2024 | VTYX Ventyx Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -34,930 | $0.00 | $0 | 34,930 | Dec 19, 2024 |
| Dec 10, 2024 | VTYX Ventyx Biosciences, Inc. | MOption exercise Common Stock | +5,377 | $0.20 | $1,075 | 270,375 | Dec 11, 2024 |
| Dec 10, 2024 | VTYX Ventyx Biosciences, Inc. | MOption exercise Common Stock | +193,557 | $0.20 | $39k | 463,932 | Dec 11, 2024 |
| Dec 10, 2024 | VTYX Ventyx Biosciences, Inc. | MOption exercise Stock Option (right to buy)derivative | -5,377 | $0.00 | $0 | 0 | Dec 11, 2024 |
| Dec 10, 2024 | VTYX Ventyx Biosciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -193,557 | $0.00 | $0 | 0 | Dec 11, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.